Concepedia

Publication | Open Access

Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison

DOIFull Paper Access

13

Citations

43

References

2023

Year

Josep‐María Ribera, Thibaud Prawitz, Andreas Freitag, Anuj Sharma, Balázs Dobi, Federica Rizzo, Lorenzo Sabatelli, Petros Patos
Advances in Therapy

Abstract

In adults with newly diagnosed Ph + ALL, first-line treatment with ponatinib was associated with better outcomes than first-line treatment with imatinib.

References

YearCitations

Page 1